This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (29)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Pulmonary and Skin Studies Before and After Treatment with Cortisone

A. SALOMON, M.D.; B. APPEL, M.D.; E. F. DOUGHERTY, M.D.; J. A. HERSCHFUS, M.D.; M. S. SEGAL, M.D.

AMA Arch Intern Med. 1955;95(1):103-111.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

GENERALIZED scleroderma is recognized as a disseminated disease which may involve not only the skin but many other organs. It is usually a chronic illness with a gradual downhill progression and lasts from months to years.

GENERAL OBSERVATIONS

The course of scleroderma can be divided into two phases: the first is characterized by Raynaud-like phenomena; the second is initiated by the appearance of constitutional symptoms, including malaise, myalgia, and arthralgia and later is characterized by the development of visceral manifestations. These later phenomena result from the structural and functional derangements consequent to the degeneration of parenchymal cells and the simultaneous proliferation of connective tissue, in such diverse systems as skin, subcutaneous tissue, muscle, tendon and fascia, bones, blood vessels, serous surfaces, internal organs, endocrine glands, and the nervous system. These widespread and continuing alterations, resulting at least in part from the proliferation of fibrous tissue, have led Goetz ¹ to . . . [Full Text PDF of this Article]

Author Affiliations
Boston

From the Departments of Inhalation Therapy and Diseases of the Skin, Boston City Hospital, and the Departments of Medicine and Dermatology and Syphilology, Tufts College Medical School; Research Fellow in Medicine, Tufts College Medical School; Chief Resident, Department of Inhalation Therapy, Boston City Hospital (Dr. Salomon); Professor and Chairman, Department of Dermatology and Syphilology, Tufts College Medical School; Physician-in-Chief for Diseases of the Skin, Boston City Hospital (Dr. Appel); Former Resident, Department of Diseases of the Skin, Boston City Hospital (Dr. Dougherty); Assistant in Medicine, Tufts College Medical School (Dr. Herschfus); Clinical Professor of Medicine, Tufts College Medical School; Director, Department of Inhalation Therapy, Boston City Hospital (Dr. Segal).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?